The author replies

New England Journal of Medicine

Volumn 371, Issue 13, 2014, Pages 1263-1264

  Connors, Jean M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GEMCITABINE; LOW MOLECULAR WEIGHT HEPARIN; PLATINUM COMPLEX; ANTICOAGULANT AGENT;

ACUTE DISEASE; BRAIN HEMORRHAGE; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER PATIENT; CENTRAL NERVOUS SYSTEM METASTASIS; CENTRAL NERVOUS SYSTEM TUMOR; CHORIOCARCINOMA; COHORT ANALYSIS; DISEASE SEVERITY; GLIOBLASTOMA; HIGH RISK PATIENT; HUMAN; KIDNEY CANCER; LETTER; MELANOMA; METASTASIS POTENTIAL; PREDICTIVE VALUE; PRIMARY TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; THROMBOCYTOPENIA; VENOUS THROMBOEMBOLISM; NEOPLASM; NOTE;

ANTICOAGULANTS; HUMANS; NEOPLASMS; VENOUS THROMBOEMBOLISM;

EID: 84907424143     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1408866     Document Type: Letter

References (5)

1. Verso M, Agnelli G, Barni S, Gasparini G, LaBianca R. A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the PROTECHT score. Intern Emerg Med 2012;7:291-2.
2. Moore RA, Adel N, Riedel E, et al. High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis. J Clin Oncol 2011;29:3466-73.
3. Ay C, Dunkler D, Marosi C, et al. Prediction of venous thromboembolism in cancer patients. Blood 2010;116:5377-82.
4. Mandybur TI. Intracranial hemorrhage caused by metastatic tumors. Neurology 1977;27:650-5.
5. Perry JR, Julian JA, Laperriere NJ, et al. PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma. J Thromb Haemost 2010;8:1959-65.